| 0 (0%) | 01-19 18:51 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 4.37  |
1-year : | 4.84 |
| Resists | First : | 3.74 |
Second : | 4.15 |
| Pivot price | 3.48 |
|||
| Supports | First : | 3.09 |
Second : | 2.57 |
| MAs | MA(5) : | 3.27 |
MA(20) : | 3.56 |
| MA(100) : | 3.87 |
MA(250) : | 3.27 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 16.7 |
D(3) : | 20.9  |
| RSI | RSI(14): 36.1 |
|||
| 52-week | High : | 5.36 | Low : | 1.61 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ LRMR ] has closed above bottom band by 16.2%. Bollinger Bands are 0.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 3.39 - 3.41 | 3.41 - 3.43 |
| Low: | 3.06 - 3.08 | 3.08 - 3.1 |
| Close: | 3.1 - 3.13 | 3.13 - 3.16 |
Fri, 16 Jan 2026
Larimar Therapeutics: The Market Is Mispricing A Potential Standard Of Care (NASDAQ:LRMR) - Seeking Alpha
Fri, 14 Nov 2025
Here's Why We're Watching Larimar Therapeutics' (NASDAQ:LRMR) Cash Burn Situation - Yahoo Finance
Wed, 05 Nov 2025
Larimar Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewswire
Wed, 22 Oct 2025
Rosen Law Firm Encourages Larimar Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – LRMR - Business Wire
Wed, 08 Oct 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Larimar Therapeutics, Inc. - LRMR - PR Newswire
Wed, 01 Oct 2025
$LRMR stock is up 28% today. Here's what we see in our data. - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 83 (M) |
| Shares Float | 37 (M) |
| Held by Insiders | 1.1 (%) |
| Held by Institutions | 103.1 (%) |
| Shares Short | 7,920 (K) |
| Shares Short P.Month | 10,080 (K) |
| EPS | -1.97 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.62 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -43 % |
| Return on Equity (ttm) | -78.3 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -1.68 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -96 (M) |
| Levered Free Cash Flow | -49 (M) |
| PE Ratio | -1.6 |
| PEG Ratio | 0 |
| Price to Book value | 1.93 |
| Price to Sales | 0 |
| Price to Cash Flow | -2.7 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|